Terminal Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Pathologically diagnosed with malignant cancer and an estimated life expectancy of less than 6 months. 2)Presence of thirst symptoms with a Visual Analog Scale (VAS) score = 5. 3)Absence of oral mucosal pathologies such as congestion, edema, erosion, or ulceration. 4)Aged 18 years or older. 5)Provided written informed consent from the patient or their legally authorized representative.
Exclusion criteria
Exclusion criteria: 1)Development of impaired consciousness or any other condition that precluded cooperation with the study procedures during the treatment period. 2)Intolerance or significant adverse reactions to the intervention. 3)Failure to complete the trial protocol as required, leading to unevaluable outcome data. 4)Inability to receive oral spray administration or to undergo saliva collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Summated Xerostomia Inventory,SXI;Unstimulated Whole Saliva Flow Rate (UWSFR); | — |
Countries
CHINA
Contacts
The First Affiliated Hospital of Zhejiang Chinese Medical University